MyFinsight
Home
Blog
About
Marketable securities
$2,073,015K
(35.70%↑ Y/Y)
Cash and cash
equivalents
$291,337K
(50.47%↑ Y/Y)
Prepaid expenses and
other current assets
$7,418K
(-40.32%↓ Y/Y)
Total property and
equipment, gross
$207,661K
(0.55%↑ Y/Y)
Total current assets
$2,371,770K
(36.81%↑ Y/Y)
Operating lease assets
$125,592K
(-8.75%↓ Y/Y)
Property and equipment,
net
$108,068K
(-13.49%↓ Y/Y)
Other non-current
assets
$37,711K
(48.05%↑ Y/Y)
Restricted cash
$7,629K
(-4.71%↓ Y/Y)
Accumulated depreciation
$99,593K
(22.05%↑ Y/Y)
Total assets
$2,650,770K
(30.60%↑ Y/Y)
Total liabilities and
shareholders equity
$2,650,770K
(30.60%↑ Y/Y)
Total shareholders'
equity
$1,746,551K
(2.07%↑ Y/Y)
Total liabilities
$904,219K
(183.82%↑ Y/Y)
Accumulated deficit
-$2,161,636K
(-26.37%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$4,629K
(-214.55%↓ Y/Y)
Treasury shares, at cost,
100,316 and 115,316...
$60K
(-3.23%↓ Y/Y)
Additional paid-in capital
$3,909,746K
(14.49%↑ Y/Y)
Long-term debt
$586,198K
Operating lease
liabilities, net of current...
$178,904K
(-9.38%↓ Y/Y)
Total current
liabilities
$132,896K
(27.34%↑ Y/Y)
Other non-current
liabilities
$6,221K
(38.99%↑ Y/Y)
Common shares, chf 0.03
nominal value,...
$3,130K
(12.03%↑ Y/Y)
Accrued expenses
$70,278K
(-4.69%↓ Y/Y)
Operating lease
liabilities
$18,646K
(3.43%↑ Y/Y)
Other current
liabilities
$16,982K
Deferred revenue,
current
$15,189K
(613.43%↑ Y/Y)
Accounts payable
$11,307K
(15.93%↑ Y/Y)
Accrued tax liabilities
$494K
(-30.91%↓ Y/Y)
Back
Back
Balance Sheet
CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG (CRSP)
source: myfinsight.com